TEOSYAL RHA\u00ae 1, TEOSYAL\u00a0 RHA\u00ae 2, TEOSYAL RHA\u00ae 3, TEOSYAL RHA\u00ae 4, TEOSYAL\u00ae PURESENSE REDENSITY 1, TEOSYAL\u00ae PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS \u00ae, and TEOSYAL\u00ae PURESENSE ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and\/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.<\/small><\/p>
Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas).<\/small><\/p>
General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.<\/small><\/p>
Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.<\/small><\/p>
Please consult your physician or pharmacist for more information.
Please refer to instructions for use<\/small><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t